Prime Medicine, Inc. (PRME)
NASDAQ·Healthcare·Biotechnology
$3.17
-5.52%
Mkt Cap $605.07M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (6 analysts)
$7.00
Range $6.00 – $8.00
Implied Upside
+121.2%
Consensus $7.00 vs current $3.17
NASDAQ·Healthcare·Biotechnology
$3.17
-5.52%
Mkt Cap $605.07M
Buy
4
Hold
0
Sell
0
Price Target (6 analysts)
$7.00
Range $6.00 – $8.00
+121.2%
Consensus $7.00 vs current $3.17